Holen Sie sich die Stockscreener-App
6.05
4.87%
-0.31
Handel nachbörslich:
6.08
0.03
+0.50%
Schlusskurs vom Vortag:
$6.36
Offen:
$6.35
24-Stunden-Volumen:
2.96M
Relative Volume:
0.61
Marktkapitalisierung:
$1.57B
Einnahmen:
$6.22B
Nettoeinkommen (Verlust:
$187.00M
KGV:
8.4426
EPS:
0.7166
Netto-Cashflow:
$508.00M
1W Leistung:
+6.14%
1M Leistung:
-7.77%
6M Leistung:
-44.19%
1J Leistung:
-53.64%
1-Tages-Spanne:
$6.005
$6.40
1-Wochen-Bereich:
$5.735
$6.40
52-Wochen-Spanne:
$5.69
$13.28
Organon Co Stock (OGN) Company Profile
Firmenname
Organon Co
Sektor
Telefon
551-430-6000
Adresse
30 HUDSON STREET, JERSEY CITY
Compare OGN vs LLY, JNJ, ABBV, AZN, MRK
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OGN
Organon Co
|
6.05 | 1.66B | 6.22B | 187.00M | 508.00M | 0.7166 |
LLY
Lilly Eli Co
|
927.06 | 835.81B | 65.18B | 20.64B | 5.96B | 22.59 |
JNJ
Johnson Johnson
|
240.97 | 585.39B | 94.19B | 26.80B | 19.70B | 11.05 |
ABBV
Abbvie Inc
|
206.69 | 369.39B | 61.16B | 4.19B | 17.82B | 2.3614 |
AZN
Astrazeneca Plc
|
202.83 | 315.58B | 58.80B | 10.24B | 8.98B | 3.2788 |
MRK
Merck Co Inc
|
120.85 | 298.84B | 64.93B | 18.26B | 12.36B | 7.2751 |
Organon Co Stock (OGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Underweight |
| 2025-10-27 | Herabstufung | Piper Sandler | Overweight → Underweight |
| 2025-05-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2024-09-06 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-11-03 | Herabstufung | Goldman | Buy → Neutral |
| 2023-09-21 | Eingeleitet | Barclays | Overweight |
| 2023-03-16 | Eingeleitet | Raymond James | Outperform |
| 2022-10-14 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-09-06 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-08-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-04-27 | Eingeleitet | Goldman | Buy |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-10-07 | Eingeleitet | Piper Sandler | Neutral |
| 2021-09-01 | Eingeleitet | BofA Securities | Buy |
| 2021-07-22 | Eingeleitet | Citigroup | Buy |
| 2021-06-15 | Eingeleitet | JP Morgan | Neutral |
| 2021-06-11 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-06-10 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Organon Co Aktie (OGN) Neueste Nachrichten
Organon & Co. Experiences Evaluation Revision Amidst Market Challenges and Performance Divergence - Markets Mojo
Can Organon Co expand into new markets2026 Dividend Review & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Philip James Wealth Mangement LLC Lowers Stock Position in Organon & Co. $OGN - MarketBeat
Total debt per share of Organon & Co. – SWB:7XP - TradingView
OGN SEC FilingsORGANON & CO 10-K, 10-Q, 8-K Forms - Stock Titan
Organon (OGN) interim manufacturing chief granted 125,208 RSUs and exercises awards - Stock Titan
Organon (OGN) CMO receives 200,333 RSUs and exercises prior award - Stock Titan
Organon (NYSE: OGN) EVP Daniel Karp receives 100,166 RSU grant and new shares - Stock Titan
[Form 4] Organon & Co. Insider Trading Activity - Stock Titan
Organon (NYSE: OGN) CFO granted 404,840 RSUs and boosts share holdings - Stock Titan
Organon (OGN) HR chief granted 166,944 RSUs and nets new shares - Stock Titan
Organon (NYSE: OGN) GC gets 183,639 RSUs, now holds 92.6K shares - Stock Titan
Organon (OGN) interim CEO awarded 333,889 RSUs, exercises RSUs and withholds shares for taxes - Stock Titan
Organon & Co. (OGN) stock price, news, quote and history - Yahoo Finance Australia
Organon & Co. (OGN) Stock Forecasts - Yahoo Finance
Organon & Co. (NYSE:OGN) Short Interest Up 18.7% in March - MarketBeat
Growth Recap: Is Organon Co subject to activist investor interest2026 PostEarnings & Low Risk High Win Rate Stock Picks - baoquankhu1.vn
Organon (NYSE: OGN) CIO exercises RSUs, 2,809 shares withheld for tax - Stock Titan
Organon (NYSE: OGN) SVP exercises RSUs; 1,516 shares withheld for tax - Stock Titan
Organon (OGN) EVP gains shares via RSU vesting and tax withholding - Stock Titan
Organon (NYSE: OGN) leader nets shares after 5,762 RSUs vest - Stock Titan
Organon (OGN) interim manufacturing chief exercises 7,979 RSUs, nets shares - Stock Titan
Organon (OGN) CMO nets more shares after 8,865 RSUs vest - Stock Titan
Organon (OGN) HR chief converts 8,422 RSUs; 2,885 shares withheld for taxes - Stock Titan
Organon (NYSE: OGN) CFO nets more shares after RSU vesting and tax withholding - Stock Titan
Organon (OGN) interim CEO converts 9,752 RSUs, 2,779 shares withheld for taxes - Stock Titan
Discipline and Rules-Based Execution in OGN Response - Stock Traders Daily
Organon trades in red for seven straight sessions - MSN
Organon & Co stock hits 52-week low at $5.76 By Investing.com - Investing.com Australia
Organon & Co. (OGN) is a trending stock: Facts to know before betting on it - MSN
Organon & Co. Hits New 52-Week Low - National Today
Organon & Co. (NYSE:OGN) Hits New 12-Month LowHere's What Happened - MarketBeat
Organon & Co. (OGN) Is Gaining Attention: Key Information to Consider Before Investing - Bitget
Organon & Co stock hits 52-week low at $5.76 - investing.com
Evaluating Organon (OGN) After A Steep Share Price And One Year Return Decline - simplywall.st
Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Organon & Co Stock: Steady Healthcare Player with Growth Potential Amid Market Pressures - AD HOC NEWS
Organon presents VTAMA cream data for atopic dermatitis at AAD By Investing.com - Investing.com Australia
Organon (OGN) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
Organon to present results from Phase 3 Adoring 1, Adoring 2 on Vtama cream - tipranks.com
Vanguard disaggregates holdings; reports 0 shares of Organon (OGN) - Stock Titan
Organon & Co. (NYSE:OGN) Receives Consensus Rating of "Reduce" from Brokerages - MarketBeat
Organon presents VTAMA cream data for atopic dermatitis at AAD - Investing.com
Organon Debuts New Analysis of VTAMA® (tapinarof) cream, 1%, Phase 3 Pooled Data Demonstrating Early and Consistent Skin Clearance and Itch Improvement in Atopic Dermatitis Patients Down to 2 Years of Age - businesswire.com
FRA:7XP PB Ratio: 2.12 — 60% Below Median - GuruFocus
Is It Time To Reassess Organon (OGN) After Its Sharp Share Price Slide - simplywall.st
Organon & Co. Stock Plummets to New 52-Week Low of $5.76 - Markets Mojo
Organon: A High Cash Yield Hidden Behind Patent Fatigue - investing.com
Organon & Co stock faces renewed scrutiny amid women's health sector shifts and pipeline updates - AD HOC NEWS
Organon sees opportunities in China's push for high-quality population development - China Daily
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - MSN
Finanzdaten der Organon Co-Aktie (OGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Organon Co-Aktie (OGN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Arjona Ferreira Juan Camilo | Head of R&D & CMO |
Mar 31 '26 |
Option Exercise |
0.00 |
13,431 |
0 |
34,867 |
| Karp Daniel | Executive VP, Corp. Dev. |
Mar 31 '26 |
Option Exercise |
0.00 |
18,053 |
0 |
71,653 |
| Stahler Rachel A | Chief Information Officer |
Mar 31 '26 |
Option Exercise |
0.00 |
18,867 |
0 |
120,322 |
| WALSH MATTHEW M | Chief Financial Officer |
Mar 31 '26 |
Option Exercise |
0.00 |
33,593 |
0 |
220,126 |
| Falcione Aaron | Chief Human Resources Officer |
Mar 31 '26 |
Option Exercise |
0.00 |
17,925 |
0 |
105,265 |
| Weaver Kirke | Gen. Counsel & Corp. Secy. |
Mar 31 '26 |
Option Exercise |
0.00 |
18,513 |
0 |
96,147 |
| Nisita Vittorio | Head of Global Business Svcs |
Mar 31 '26 |
Option Exercise |
0.00 |
13,000 |
0 |
73,494 |
| Holzbaur Lynette | SVP and Corporate Controller |
Mar 31 '26 |
Option Exercise |
0.00 |
10,967 |
0 |
28,316 |
| Morrissey Joseph T. Jr. | Interim CEO |
Mar 31 '26 |
Option Exercise |
0.00 |
24,584 |
0 |
127,907 |
| Stahler Rachel A | Chief Information Officer |
Mar 29 '26 |
Option Exercise |
0.00 |
8,200 |
0 |
106,510 |
1.73%
0.30%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):